(2,3-Dimethylpyridin-4-yl)boronic Acid is used to prepare substituted azaanthracene derivatives as GLP-1 receptor modulators useful in the treatment of GLP-1 receptor-mediated diseases
參考文獻
Mjalli, A., et al.: PCT Int. Appl.В?(2010),В?WOВ?2010114824В?A1В?20101007